THERMO FISHER SCIENTIFIC INC.

Thermo Fisher Scientific Inc., CIK 97745, blends laboratory instruments, reagents, and software with mission-critical services for research, clinical, and industrial clients, anchoring its global reach in the scientific instruments SIC context while also spanning custom manufacturing for pharmaceutical, biotech, and hospital lab partners; its portfolio includes analytical instruments, high-throughput sequencing platforms, lab consumables, and contract development and manufacturing services, all supported by compliance and consulting teams that help customers accelerate drug discovery and production. The company’s scale in servicing regulated industries means that compliance with FDA, EMA, and environmental regulations, along with supply chain stability and potential pricing pressures in the diagnostics and biopharma markets, remain material risks, especially as regulatory scrutiny of lab practices and cross-border trade intensifies, and while the most recent SEC filing specifics are pending, investors should watch for updates that could illuminate near-term capital deployment or divestiture strategies before the next annual report. View live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025